Integra Lifesciences | 8-K: Integra LifeSciences Reports First Quarter 2024 Financial Results
Integra Lifesciences | DEF 14A: Definitive information statements
Integra Lifesciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | 8-K: Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
Integra Lifesciences | 8-K/A: Current report (Amendment)
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | 8-K: Integra LifeSciences Reports Third Quarter 2023 Financial Results
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | 8-K: Integra LifeSciences Reports Second Quarter 2023 Financial Results
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | 8-K: Integra LifeSciences Reports First Quarter 2023 Financial Results
Integra Lifesciences | DEF 14A: Definitive proxy statements
Integra Lifesciences | 8-K: Current report
Integra Lifesciences | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Integra Lifesciences | 8-K: Integra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
No Data